• Patel Savankumar Pravinbhai
• Narkhede Kantilal B.
• Narkhede Sachin B.

Asthma is chronic inflammatory disease of the airways that causes airway hyper responsiveness, mucosal edema, and mucus production. World-wide approximately 300 million people have asthma. Acebrophylline is a bronchodilator with mucosecretolytic and anti-inflammatory activity. Acebrophylline inhibits intracellular phosphodiesterase and facilitates brochial muscles relexation by increasing cAMP levels Acebrophylline is good highly effective within the treatment of the Bronchial Asthama. Lozenges are solid preparations that contain one or more medicaments, usually during a flavoured, sweetened base, and are intended to dissolve or disintegrate slowly within the mouth or these are medicated candy intended to be dissolved slowly within the mouth.

Asthma, Acebrophylline , Lozenges Drug Delivery, Heating and congealing method

"A Review on Acebrophylline Lozenges for bronchial Asthma: A Novel Approach", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.7, Issue 3, page no.1150-1156, March-2020, Available :http://www.jetir.org/papers/JETIR2003171.pdf

"A Review on Acebrophylline Lozenges for bronchial Asthma: A Novel Approach", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.7, Issue 3, page no. pp1150-1156, March-2020, Available at : http://www.jetir.org/papers/JETIR2003171.pdf